Comparative Efficacy of Adagrasib and Sotorasib in KRAS G12C-Mutant NSCLC: Insights from Pivotal Trials.

It is important to note that the RMST differences between the treatments did not reach statistical significance at any timepoint for either PFS or OS, as illustrated in Figure 2 and Figure 3 and summarized in Table 3 . 3.5.

also in 111,027 other papers